This filing is part of the company’s quarterly result. Read the full results article, with every figure explained →
Announcement under Regulation 30 (LODR) - Press Release
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.1 pts less than Nifty Microcap 250 and 0.9 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Kerala Ayurveda Ltd reported consolidated Q1 FY26 revenue of Rs. 39.8 Crs, up 43.7% year-on-year (37.6% excluding Ayurvedagram Bali), driven by India Digital (44% growth), US Wellness Centers (90% growth), and Ayurvedagram Bangalore (20% growth). The company posted its first adjusted EBITDA profit of Rs. 6.4 Crs (excluding ESOP provisions), a swing of Rs. 5.4 Crs from the previous year, with reported EBITDA at Rs. 5.3 Crs and PAT at Rs. 2.03 Crs (up Rs. 1.57 Crs YoY). Results include a one-time Rs. 8.04 Crs gain from sale of land booked under other income. Core operating revenue growth (excluding one-time base effects) was 17%. Management has set a target to double the topline growth rate to 50% in FY26 and plans to raise funds in the near term to invest in marketing, technology, and international expansion.
This is a positive operating update showing a clear turnaround in profitability with first adjusted EBITDA profit and strong top-line growth across priority segments. The planned fundraise to support a 50% growth target could lead to dilution, which shareholders should watch for.
| Q1 FY26 | Q1 FY25 | Change | |
|---|---|---|---|
| Revenue | ₹28.61 Cr | ₹28.64 Cr | −0.1% |
| Operating profit | −₹6.66 Cr | −₹0.01 Cr | loss widened |
| Profit after tax | ₹2.03 Cr | ₹0.46 Cr | +340.9% |
| EBITDA margin | -14.6% | 2.8% | −17.4 pp |
From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.